NCT07264062
MetSense Pilot and Feasibility
Enrolling by Invitation
NAAges 18+InterventionalPreventionKaiser PermanenteInvestigator-initiated
~20,000 participants
Updated 2026-02-27 on ClinicalTrials.gov
What's tested:MetSense Risk FlagUsual Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent with completed hemoglobin A1c test within 6 months.
Measured over 6 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Esti Iturralde, PhD · PRINCIPAL_INVESTIGATOR · KPNC Division of Research
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18 or older
Diagnosed with schizophrenia, another psychotic disorder, or bipolar disorder
Included in a clinical pharmacist population management program for serious mental illness within Kaiser Permanente Northern California
What this trial measures
- Percent with completed hemoglobin A1c test within 6 months.6 months
Laboratory test completion